Login to Your Account

Pharma: Other News To Note

Friday, June 7, 2013
• Actavis Inc., of Parsippany, N.J., said it filed an abbreviated new drug application to market drospirenone/ethinyl estradiol/lovomefolate calcium tablets and levomefolate calcium tablets, a generic version of Safyral from Bayer AG, of Leverkusen, Germany.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription